Vivet Therapeutics - innovative gene therapy treatments for orphan diseases

innovative gene therapy treatments for orphan diseases

About us
Pipeline
Investors
News
Events
Patients & Families
Work at Vivet

VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Vivet Therapeutics → Events → VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

BACK

Jan

Date 7 January 2019

Categories Events

VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jean-Philippe Combal, Vivet Therapeutics’ CEO, Dr. Gloria Gonzalez, its CSO and Thomas Daniel, BD Director will be at the 37th Annual J.P. Morgan Healthcare Conference on January 7-10, 2019.

Author admin_viv3t

BACK

Last news

Vivet Therapeutics Doses First Patient in Cohort 2 in Phase 1/2 GATEWAY Clinical Trial for Treatment of Wilson Disease8 April 2024
Rare Disease Day – February 2926 February 2024
Vivet Therapeutics receives EUR 4.9 million to advance development of a gene therapy1 February 2024
Vivet Therapeutics Announces Presentations at Upcoming European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress23 October 2023
Vivet Therapeutics awarded with the Prix Galien MedStartup in New York28 October 2021

All NEWS

Last events

Cell & Gene Meeting on the Med4 April 2024
7th Annual Gene Therapy for Rare Disorders Summit25 March 2024
J.P.Morgan 2024 – Annual Healthcare Conference in San Francisco4 January 2024
Vivet spronsoring and attending the Spanish Wilson disease patients association annual conference in Valencia, Spain15 November 2023
AASLD – The Liver Meeting in Boston6 November 2023
ESGCT’s 30th Annual Congress in Brussels24 October 2023